Pharmaceutical News and Articles

Trump Blocks Federal Funds for Schools That Require COVID Vaccines

and while young people are less likely to suffer severe illness, the virus has still harmed many kids.Research shows that vaccine rules in schools helped more s

Student Athletes Don't Know How To Fuel With Food, Study Says

High school athletes often hit the field improperly fueled for the competition ahead, because they haven t been taught important basics of nutrition, a new stud

Juicing Diets Can Harm Health in Just 3 Days, Study Finds

TUESDAY, Feb. 18, 2025 Juice cleanses are a popular way to kickstart a health journey, but these diets may do more harm than good in as little as three days. A

Adults Can Learn 'Perfect Pitch,' Study Suggests

From Mariah Carey and Jimi Hendrix to Michael Jackson, Ella Fitzgerald and Bing Crosby, a select group of famous musicians past and present have had have perfec

Black Children Less Likely To Get Gene Tests for Neuro Disorders

Extensive genetic testing is recommended for all children with epilepsy, unexplained developmental delays, autism and other neurological conditions. New researc

Smog During Pregnancy Threatens Newborn Health

Newborns are more likely to be born sickly if their moms are exposed to air pollution during pregnancy, a new study says. A woman s exposure to air pollution du

FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog

Lundbeck’s Potential Treatment Amlenetug for Multiple System Atrophy Receives Fast Track Designation From the FDA

The FDA has granted Fast Track Designation to Lundbeck s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MS

FDA Grants Fast Track Designation to PleoPharma, Inc's Investigational New Drug, PP-01, for the Mitigation of Cannabis Withdrawal Symptoms in Patients With Cannabis Use Disorder

PleoPharma, Inc., a privately held company focused on finding treatments for cannabis related health issues, announced today that the U.S. Food and Drug Adminis

Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome

Innate Pharma SA (Euronext Paris IPH Nasdaq IPHA) ( Innate or the Company ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakth